Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Feb;87(3):1411-9.
doi: 10.1128/JVI.02682-12. Epub 2012 Nov 14.

The hemagglutinin protein of highly pathogenic H5N1 influenza viruses overcomes an early block in the replication cycle to promote productive replication in macrophages

Affiliations

The hemagglutinin protein of highly pathogenic H5N1 influenza viruses overcomes an early block in the replication cycle to promote productive replication in macrophages

Troy D Cline et al. J Virol. 2013 Feb.

Abstract

Macrophages are known to be one of the first lines of defense against influenza virus infection. However, they may also contribute to severe disease caused by the highly pathogenic avian (HPAI) H5N1 influenza viruses. One reason for this may be the ability of certain influenza virus strains to productively replicate in macrophages. However, studies investigating the productive replication of influenza viruses in macrophages have been contradictory, and the results may depend on both the type of macrophages used and the specific viral strain. In this work, we investigated the ability of H1 to H16 viruses to productively replicate in primary murine alveolar macrophages and RAW264.7 macrophages. We show that only a subset of HPAI H5N1 viruses, those that cause high morbidity and mortality in mammals, can productively replicate in macrophages, as measured by the release of newly synthesized virus particles into the cell supernatant. Mechanistically, we found that these H5 strains can overcome a block early in the viral life cycle leading to efficient nuclear entry, viral transcription, translation, and ultimately replication. Studies with reassortant viruses demonstrated that expression of the hemagglutinin gene from an H5N1 virus rescued replication of H1N1 influenza virus in macrophages. This study is the first to characterize H5N1 influenza viruses as the only subtype of influenza virus capable of productive replication in macrophages and establishes the viral gene that is required for this characteristic. The ability to productively replicate in macrophages is unique to H5N1 influenza viruses and may contribute to their increased pathogenesis.

PubMed Disclaimer

Figures

Fig 1
Fig 1
H5N1 influenza viruses productively infect RAW cells. RAW264.7 cells were infected in triplicate with a panel of influenza viruses representing all 16 HA subtypes (A [the viruses are listed in Table 1]) or with the indicated viruses (B) at an MOI of 0.01. At the indicated times postinfection, the medium was collected, and virus titers were determined by TCID50 analysis in triplicate. (C) RAW cells were infected with the indicated influenza viruses (MOI = 3). The medium was collected at 24 and 48 hpi, and virus titers were determined by TCID50 analysis. (D) Primary murine alveolar macrophages were infected with the indicated viruses (MOI = 3), cell supernatants were collected at 24 and 48 h postinfection, and virus titers were determined as described above (limit of detection = 102 TCID50/ml). The data are representative of duplicate experiments. Error bars represent the mean TCID50 value ± the standard deviation. Titers determined at 1 hpi were below the limit of detection for the H5 viruses and ranged from below the limit of detection to 102 TCID50/ml for H1 and H3 viruses.
Fig 2
Fig 2
NP staining decreases in macrophages infected with CA/09. RAW264.7 macrophages (A) or MDCK cells (B) seeded onto coverslips were incubated with CA/09 or HK/483 (MOI = 5) on ice for 1 h. At time zero, warm infection medium was added, and the cells were incubated at 37°C. At the indicated time points, the cells were fixed and processed for immunofluorescent staining to detect viral NP. The slides were viewed by confocal microscopy as described in Materials and Methods. The mean percent NP+ macrophages was quantified from three independent images and is indicated in the lower right corner of each panel (A). Nuclei were visualized by DAPI staining, and representative images from two independent experiments are shown.
Fig 3
Fig 3
RNA synthesis is inhibited in CA/09-infected macrophages. A549 (A) or RAW (B) cells were incubated with HK/483 or CA/09 at 4°C for 1 h. At time zero, warm medium was added, and the cells were incubated at 37°C. At the indicated time points, total RNA was isolated, and the levels of vRNA, mRNA, and cRNA were determined in triplicate using primers that amplify the NP gene as described in Materials and Methods. The RNA level in HK/483-infected cells at 12 hpi was set as a value of 1.0, and all other samples are presented relative to that amount. Viral RNA levels were normalized to GAPDH and to the amount of RNA present at 30 min postinfection. The data are representative of two independent experiments. The primer sequences are presented in Table 2.
Fig 4
Fig 4
Viral protein synthesis is blocked during CA/09 infection of macrophages. RAW264.7 (left panels) or MDCK (right panels) cells were infected with HK/483 or CA/09, and the cells were lysed at the indicated times postinfection. Proteins were separated by SDS-PAGE under reducing conditions, transferred to nitrocellulose, and probed with anti-NS1 (top panels) or anti-actin (bottom panels) by Western blotting.
Fig 5
Fig 5
The HA gene mediates replication of influenza viruses in macrophages. (A) RAW264.7 cells were infected with the parental reverse genetics (rg) viruses or with rgCA/09 expressing individual genes from HK/483 (MOI = 0.1). Cell culture supernatants were collected at 24 hpi, and virus titers were determined by TCID50 analysis. (B) RAW264.7 cells were infected with the indicated viruses, and the virus titers determined as described for panel A. (C) RAW264.7 cells were infected with the indicated reverse genetics viruses as described above. The medium was collected 24 hpi, and virus titers were determined by TCID50 analysis on MDCK cells. Error bars represent the mean value ± the SD.

References

    1. Chen H, Smith GJ, Li KS, Wang J, Fan XH, Rayner JM, Vijaykrishna D, Zhang JX, Zhang LJ, Guo CT, Cheung CL, Xu KM, Duan L, Huang K, Qin K, Leung YH, Wu WL, Lu HR, Chen Y, Xia NS, Naipospos TS, Yuen KY, Hassan SS, Bahri S, Nguyen TD, Webster RG, Peiris JS, Guan Y. 2006. Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc. Natl. Acad. Sci. U. S. A. 103:2845–2850 - PMC - PubMed
    1. Baskin CR, Bielefeldt-Ohmann H, Tumpey TM, Sabourin PJ, Long JP, Garcia-Sastre A, Tolnay AE, Albrecht R, Pyles JA, Olson PH, Aicher LD, Rosenzweig ER, Murali-Krishna K, Clark EA, Kotur MS, Fornek JL, Proll S, Palermo RE, Sabourin CL, Katze MG. 2009. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc. Natl. Acad. Sci. U. S. A. 106:3455–3460 - PMC - PubMed
    1. Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, Shortridge KF, Gordon S, Guan Y, Peiris JS. 2002. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 360:1831–1837 - PubMed
    1. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, Qui PT, Cam BV, Ha do Q, Guan Y, Peiris JS, Chinh NT, Hien TT, Farrar J. 2006. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12:1203–1207 - PMC - PubMed
    1. Perrone LA, Plowden JK, Garcia-Sastre A, Katz JM, Tumpey TM. 2008. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog. 4:e1000115 doi:10.1371/journal.ppat.1000115 - DOI - PMC - PubMed

Publication types

MeSH terms

Substances